← All trials
NCT03620474
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 24, 2018
- Primary completion
- Feb 29, 2020
- Completion date
- Jul 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 34
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tokyo Metropolitan Komagome HospitalLead sponsor
- National Center for Global Health and MedicineCollaborator
- Prism ResearchCollaborator
- Tokyo Metropolitan Komagome HospitalReponsible party - principal investigator
- Tokyo Metropolitan Komagome HospitalOverall official - principal investigator
- Japan Agency for Medical Research and DevelopmentCollaborator
- Kyushu UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.